The role of vaccines in the COVID-19 pandemic: what have we learned?
被引:15
|
作者:
Krammer, Florian
论文数: 0引用数: 0
h-index: 0
机构:
Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA
Icahn Sch Med Mt Sinai, Ctr Vaccine Res & Pandem Preparedness C VaRPP, New York, NY 10029 USA
Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based Med, New York, NY 10029 USAIcahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA
Krammer, Florian
[1
,2
,3
]
机构:
[1] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Ctr Vaccine Res & Pandem Preparedness C VaRPP, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based Med, New York, NY 10029 USA
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged late in 2019 and caused the coronavirus disease 2019 (COVID-19) pandemic that has so far claimed approximately 20 million lives. Vaccines were developed quickly, became available in the end of 2020, and had a tremendous impact on protection from SARS-CoV-2 mortality but with emerging variants the impact on morbidity was diminished. Here I review what we learned from COVID-19 from a vaccinologist's perspective.
机构:
Univ Sao Paulo, Fac Med, Hosp Clin, Div Molestias Infecciosas & Parasitarias, Sao Paulo, SP, BrazilUniv Sao Paulo, Fac Med, Hosp Clin, Div Molestias Infecciosas & Parasitarias, Sao Paulo, SP, Brazil
Ho, Yeh-Li
Miethke-Morais, Anna
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sao Paulo, Fac Med, Hosp Clin, Gestao Assistencial Corporat,Diretoria Clin, Sao Paulo, SP, BrazilUniv Sao Paulo, Fac Med, Hosp Clin, Div Molestias Infecciosas & Parasitarias, Sao Paulo, SP, Brazil